EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

A Covalent and Modulable Inhibitor of the Tubulin‐Microtubule System: Insights Into the Mechanism of Cacalol

Edgar López-López iD, José L Medina-Franco iD, Eric Salinas-Arellano iD, Karen J Ardila-Fierro iD, Julio C Pardo-Novoa iD, Rosa E Del Río iD, Carlos M Cerda-García-Rojas iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70165 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2025. Written by Edgar López-López and 6 co-authors. Institution: Departamento de Química y Programa de Posgrado en Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, M…. Major MEDLINE topics: Tubulin, Microtubules, Tubulin Modulators, Antineoplastic Agents. Cited 3 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: Secretaría de Ciencia, Humanidades, Tecnología e Innovación (Secihti), Mexico, Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Inhibitors of the tubulin‐microtubule system are part of an effective strategy to treat different kinds of cancer, whose research has allowed scientists to discover and develop new and more selective molecules. Cacalol ( 1 ) is a natural product with anti‐cancer activity and documented selectivity in breast cells, but with an undescribed molecular mechanism associated with these properties. The main objective of this work is to provide evidence that helps to explain the inhibitory and selective activity reported for cacalol ( 1 ) against cancer cell lines and to expand the knowledge about the mechanism of action involved in it. Cacalol derivatives were studied using reactivity approaches, tubulin polymerization assays, mass spectrometry, and molecular modeling techniques to decode the inhibitory binding mechanism. This work demonstrates that an oxidated form of cacalol, the methylenecyclohexadienone 2 , is generated in highly oxidant conditions, thus emulating the environment present in cancer cells. This species ( 2 ) is responsible for the inhibition of tubulin polymerization by promoting an irreversible binding interaction with the Cys347 in α‐tubulin.

Subjects

MeSH terms (MEDLINE)

TubulinMicrotubulesTubulin ModulatorsAntineoplastic AgentsHumansCell Line, TumorBinding SitesProtein BindingPolymerization

Author keywords

ROS‐dependent inhibitorscovalent inhibitorsmolecular dynamicsnaphthofuran derivativespeptide mass spectrometrypolymerization inhibitorstubulin‐microtubules system

Substances

TubulinTubulin ModulatorsAntineoplastic Agents

Authors and institutions

  • Departamento de Química y Programa de Posgrado en Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
  • DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Departamento de Ciencias de la Tierra y de la Vida, Centro Universitario de los Lagos, Universidad de Guadalajara, Lagos de Moreno, Jalisco, Mexico.
  • Grupo Ciencia de los Materiales, Instituto de Química, Facultad de Ciencias Exactas y Naturales, Universidad de Antioquia, Medellín, Colombia.
  • Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Ciudad Universitaria, Morelia, Michoacán, Mexico.

ORCID profiles: Edgar López-López, José L Medina-Franco, Eric Salinas-Arellano, Karen J Ardila-Fierro, Julio C Pardo-Novoa, Rosa E Del Río, Carlos M Cerda-García-Rojas

Funding

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (Secihti), Mexico
  • Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT)
  • Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México

Cite

APA

López-López, E., Medina-Franco, J. L., Salinas-Arellano, E., Ardila-Fierro, K. J., Pardo-Novoa, J. C., Del Río, R. E., & Cerda-García-Rojas, C. M. (2025). A Covalent and Modulable Inhibitor of the Tubulin‐Microtubule System: Insights Into the Mechanism of Cacalol. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70165

Vancouver

López-López E, Medina-Franco JL, Salinas-Arellano E, Ardila-Fierro KJ, Pardo-Novoa JC, Del Río RE, et al. A Covalent and Modulable Inhibitor of the Tubulin‐Microtubule System: Insights Into the Mechanism of Cacalol. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70165

BibTeX
@article{LpezLpez2025,
  author = {López-López, Edgar and Medina-Franco, José L and Salinas-Arellano, Eric and Ardila-Fierro, Karen J and Pardo-Novoa, Julio C and Del Río, Rosa E and Cerda-García-Rojas, Carlos M},
  title = {A Covalent and Modulable Inhibitor of the Tubulin‐Microtubule System: Insights Into the Mechanism of Cacalol},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70165}
}
Start for free →